TALENCE

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Scission partielle",
      "value": "Scission partielle",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-08-11",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 11/08/2026 - Annexes du Moniteur belge",
      "value": "11/08/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-08-03",
      "type": "filing",
      "quote": "03 AOUT 2026",
      "value": "03/08/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-10",
      "type": "notarial_deed",
      "quote": "D\u0027un proc\u00E8s-verbal dress\u00E9 par Edouard-Jean NAVEZ, notaire associ\u00E9 \u00E0 la r\u00E9sidence de Grez-Doiceau le 10 juillet 2026",
      "value": "10/07/2026",
      "object": "e3",
      "subject": "e1"
    },
    {
      "date": "2026-07-10",
      "type": "general_meeting",
      "quote": "D\u0027un proc\u00E8s-verbal dress\u00E9 par Edouard-Jean NAVEZ, notaire associ\u00E9 \u00E0 la r\u00E9sidence de Grez-Doiceau le 10 juillet 2026 ... il r\u00E9sulte que l\u0027assembl\u00E9e de la soci\u00E9t\u00E9 anonyme \u00AB BePharBel Manufacturing \u00BB a pris les r\u00E9solutions",
      "value": "10/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "demerger",
      "quote": "L\u0027assembl\u00E9e d\u00E9cide ... la scission partielle de la pr\u00E9sente soci\u00E9t\u00E9 par constitution d\u0027une soci\u00E9t\u00E9 anonyme \u003C Novaform Pharma \u00BB ... Cette scission partielle aura pour effet l\u0027apport de la branche d\u0027activit\u00E9s MMCR",
      "value": {
        "description": "Scission partielle par constitution d\u0027une soci\u00E9t\u00E9 anonyme Novaform Pharma. Transfert de la branche d\u0027activit\u00E9s MMCR."
      },
      "object": "e2",
      "subject": "e1"
    },
    {
      "date": "2025-12-31",
      "type": "net_asset_statement",
      "quote": "Ce transfert comprend, sur base de la situation arr\u00EAt\u00E9e au 31 d\u00E9cembre 2025 ... Total 5.720.586 EUR",
      "value": {
        "date": "31/12/2025",
        "amount": 5720586,
        "currency": "EUR"
      },
      "amount": 5720586.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR"
    },
    {
      "type": "capital_decrease",
      "quote": "l\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital de la soci\u00E9t\u00E9 \u00E0 concurrence de 4.238.390 euros pour le ramener de 11.902.532,35 euros \u00E0 7.664.142,35 euros sans annulation de titres.",
      "value": {
        "after": 7664142.35,
        "delta": -4238390,
        "amount": 7664142.35,
        "before": 11902532.35,
        "currency": "EUR"
      },
      "amount": -4238390.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": 7664142.35,
        "delta": -4238390,
        "before": 11902532.35,
        "currency": "EUR"
      }
    },
    {
      "type": "capital",
      "quote": "ARTICLE 5- CAPITAL Le capital est fix\u00E9 \u00E0 7.664.142,35 EUR. Il est repr\u00E9sent\u00E9 par 996.268 actions",
      "value": {
        "amount": 7664142.35,
        "shares": 996268,
        "currency": "EUR"
      },
      "amount": 7664142.35,
      "object": null,
      "subject": "e1",
      "currency": "EUR"
    },
    {
      "type": "share_issue",
      "quote": "En r\u00E9mun\u00E9ration de ce transfert. il sera attribu\u00E9 imm\u00E9diatement et directement aux actionnaires 996.268 actions enti\u00E8rement lib\u00E9r\u00E9es de la soci\u00E9t\u00E9 b\u00E9n\u00E9ficiaire.",
      "value": {
        "count": 996268,
        "description": "Actions enti\u00E8rement lib\u00E9r\u00E9es attribu\u00E9es aux actionnaires de la soci\u00E9t\u00E9 scind\u00E9e"
      },
      "object": null,
      "subject": "e2"
    },
    {
      "type": "share_transfer",
      "quote": "Sambrinvest Spin-Off/Spin-Out SA ... 63.640 6,39%",
      "value": {
        "count": 63640,
        "percentage": "6,39%"
      },
      "object": "e4",
      "subject": "e1"
    },
    {
      "type": "share_transfer",
      "quote": "Iris Belgium SRL ... 176.726 17.74%",
      "value": {
        "count": 176726,
        "percentage": "17,74%"
      },
      "object": "e5",
      "subject": "e1"
    },
    {
      "type": "share_transfer",
      "quote": "Talence SA ... 86.890 8,72%",
      "value": {
        "count": 86890,
        "percentage": "8,72%"
      },
      "object": "e6",
      "subject": "e1"
    },
    {
      "type": "share_transfer",
      "quote": "Vinsovier Soci\u00E9t\u00E9 simple ... 210.832 21,16%",
      "value": {
        "count": 210832,
        "percentage": "21,16%"
      },
      "object": "e7",
      "subject": "e1"
    },
    {
      "type": "share_transfer",
      "quote": "CANA Soci\u00E9t\u00E9 simple ... 58.483 5,87%",
      "value": {
        "count": 58483,
        "percentage": "5,87%"
      },
      "object": "e8",
      "subject": "e1"
    },
    {
      "type": "share_transfer",
      "quote": "Monsieur Georges Guillaume ... 3.746 0,38%",
      "value": {
        "count": 3746,
        "percentage": "0,38%"
      },
      "object": "e9",
      "subject": "e1"
    },
    {
      "type": "share_transfer",
      "quote": "Monsieur Pascal Lizin ... 3.829 0,38%",
      "value": {
        "count": 3829,
        "percentage": "0,38%"
      },
      "object": "e10",
      "subject": "e1"
    },
    {
      "type": "share_transfer",
      "quote": "Nomainvest SA ... 252.041 25,30%",
      "value": {
        "count": 252041,
        "percentage": "25,30%"
      },
      "object": "e11",
      "subject": "e1"
    },
    {
      "type": "share_transfer",
      "quote": "Wallonie Entreprendre ... 140.081 14.06%",
      "value": {
        "count": 140081,
        "percentage": "14,06%"
      },
      "object": "e12",
      "subject": "e1"
    },
    {
      "type": "power_of_attorney",
      "quote": "L\u0027assembl\u00E9e conf\u00E8re \u00E0 Madame Julia PIEKUNKO, pr\u00E9qualifi\u00E9e, les pouvoirs les plus \u00E9tendus aux fins de veiller au d\u00E9roulement des op\u00E9rations de scission partielle...",
      "value": "Pouvoirs les plus \u00E9tendus aux fins de veiller au d\u00E9roulement des op\u00E9rations de scission partielle et \u00E0 l\u0027application des effets l\u00E9gaux de cette scission.",
      "object": "e1",
      "subject": "e13"
    },
    {
      "type": "permanent_representative",
      "quote": "La SA SPARAXIS ... laquelle d\u00E9signe en qualit\u00E9 de repr\u00E9sentant permanent, Monsieur LEFEBVRE Gery...",
      "value": null,
      "object": "e19",
      "subject": "e20"
    },
    {
      "type": "mandate_compensation",
      "quote": "Leur mandat est gratuit.",
      "value": "gratuit",
      "object": null,
      "subject": "e18"
    },
    {
      "type": "mandate_compensation",
      "quote": "Leur mandat est gratuit.",
      "value": "gratuit",
      "object": null,
      "subject": "e19"
    },
    {
      "type": "power_of_attorney",
      "quote": "L\u0027assembl\u00E9e conf\u00E8re \u00E0 l\u0027unanimit\u00E9 tous pouvoirs aux administrateurs et au notaire soussign\u00E9 ... pour l\u0027ex\u00E9cution des r\u00E9solutions qui pr\u00E9c\u00E8dent et, notamment, pour accomplir les formalit\u00E9s n\u00E9cessaires...",
      "value": "Tous pouvoirs pour l\u0027ex\u00E9cution des r\u00E9solutions et accomplir les formalit\u00E9s n\u00E9cessaires aupr\u00E8s de toutes administrations comp\u00E9tentes.",
      "object": "e1",
      "subject": "e21"
    }
  ],
  "act_meta": {
    "outcome": "review",
    "postfix": [
      "proposal act: dropped 5 restated officer fact(s)"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 29914,
    "truncated": false,
    "lengthcap_fallback": [
      "verify:budget2000"
    ]
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0844.689.955",
      "kind": "company",
      "name": "BePharBel Manufacturing",
      "attrs": {
        "seat": "6180 Courcelles, rue du Luxembourg 13",
        "legal_form": "SA"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "company",
      "name": "Novaform Pharma",
      "attrs": {
        "seat": "6180 Courcelles, rue du Luxembourg 13",
        "legal_form": "SA"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Edouard-Jean NAVEZ",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": "0884.341.575",
      "kind": "company",
      "name": "Sambrinvest Spin-Off/Spin-Out SA",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": "0540.792.024",
      "kind": "company",
      "name": "Iris Belgium SRL",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": "0841.369.288",
      "kind": "company",
      "name": "Talence SA",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "company",
      "name": "Vinsovier Soci\u00E9t\u00E9 simple",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "company",
      "name": "CANA Soci\u00E9t\u00E9 simple",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Georges Guillaume",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Pascal Lizin",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": "0460.996.458",
      "kind": "company",
      "name": "Nomainvest SA",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": "0793.630.244",
      "kind": "company",
      "name": "Wallonie Entreprendre",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Julia PIEKUNKO",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": "0841.369.288",
      "kind": "company",
      "name": "Talence SA",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Jean-Jacques DELENS",
      "attrs": {}
    },
    {
      "id": "e16",
      "kbo": null,
      "kind": "person",
      "name": "Cyril WOLKONSKI",
      "attrs": {}
    },
    {
      "id": "e17",
      "kbo": null,
      "kind": "person",
      "name": "Yves-G\u00E9rard NOEL",
      "attrs": {}
    },
    {
      "id": "e18",
      "kbo": null,
      "kind": "person",
      "name": "Philippe NIESSEN",
      "attrs": {
        "address": "4701 Eupen, Zur Nohn, 24",
        "birth_date": "1990-05-27",
        "birth_place": "Eupen"
      }
    },
    {
      "id": "e19",
      "kbo": "0452.116.307",
      "kind": "company",
      "name": "SPARAXIS",
      "attrs": {
        "seat": "4000 Li\u00E8ge, avenue Maurice-Destenay 13"
      }
    },
    {
      "id": "e20",
      "kbo": null,
      "kind": "person",
      "name": "Gery LEFEBVRE",
      "attrs": {
        "address": "4000 Li\u00E8ge, Quai de Rome, 46/0021",
        "birth_date": "1972-12-28",
        "birth_place": "Ch\u00EAn\u00E9e"
      }
    },
    {
      "id": "e21",
      "kbo": null,
      "kind": "person",
      "name": "Beno\u00EEt COLMANT",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : CONSTITUTION",
      "value": "CONSTITUTION",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-15",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 15/07/2026 - Annexes du Moniteur belge",
      "value": "15/07/2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-13",
      "type": "filing",
      "quote": "D\u00E9pos\u00E9 13-07-2026",
      "value": "13-07-2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-10",
      "type": "notarial_deed",
      "quote": "Extrait de l\u2019acte constitutif re\u00E7u par Edouard-Jean NAVEZ, notaire associ\u00E9 \u00E0 la r\u00E9sidence de Grez-Doiceau, en date du 10 juillet 2026",
      "value": "10 juillet 2026",
      "object": "e3",
      "subject": "e1"
    },
    {
      "date": "2026-07-10",
      "type": "incorporation",
      "quote": "La soci\u00E9t\u00E9 comparante requiert le notaire soussign\u00E9 d\u2019acter que suite \u00E0 la d\u00E9cision de scission partielle, une soci\u00E9t\u00E9 anonyme \u00AB NOVAFORM PHARMA \u00BB est constitu\u00E9e",
      "value": "10 juillet 2026",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2026-07-10",
      "type": "demerger",
      "quote": "la scission sera r\u00E9alis\u00E9e, sans que la soci\u00E9t\u00E9 cesse d\u2019exister, par transfert d\u2019une partie de son patrimoine actif et passif \u00E0 la pr\u00E9sente soci\u00E9t\u00E9 anonyme qu\u2019elle constitue",
      "value": {
        "date": "10 juillet 2026",
        "type": "scission partielle par constitution de soci\u00E9t\u00E9 nouvelle"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "founder",
      "quote": "FONDATEUR \u0022BEPHARBEL MANUFACTURING\u0022 soci\u00E9t\u00E9 anonyme",
      "value": null,
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "power_of_attorney",
      "quote": "la soci\u00E9t\u00E9 scind\u00E9e partiellement sera repr\u00E9sent\u00E9e par Madame Julia PIEKUNKO. Les pouvoirs les plus \u00E9tendus ont \u00E9t\u00E9 conf\u00E9r\u00E9s au mandataire ci-avant d\u00E9sign\u00E9 aux fins de veiller au d\u00E9roulement des op\u00E9rations de scission",
      "value": "veiller au d\u00E9roulement des op\u00E9rations de scission et \u00E0 l\u2019application des effets l\u00E9gaux de cette scission",
      "object": "e2",
      "subject": "e6"
    },
    {
      "type": "purpose",
      "quote": "ARTICLE 3 \u2013 OBJET",
      "value": "La soci\u00E9t\u00E9 a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et \u00E0 l\u0027\u00E9tranger, la recherche, le d\u00E9veloppement, la mise au point, la fabrication, la production, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation et l\u0027exportation, et la transformation : de tous produits chimiques, pharmaceutiques, biologiques, biotechnologiques, de th\u00E9rapie avanc\u00E9e, ainsi que tous les produits de sant\u00E9, diagnostics, dispositifs m\u00E9dicaux, v\u00E9t\u00E9rinaires et plus g\u00E9n\u00E9ralement de tous les produits se rapportant directement ou indirectement aux sciences de la vie ; de tous produits interm\u00E9diaires, substances actives, mati\u00E8res premi\u00E8res, composants, consommables et d\u00E9riv\u00E9s utiles ou n\u00E9cessaires aux activit\u00E9s susmentionn\u00E9es ; de tous \u00E9quipements, installations, technologies, proc\u00E9d\u00E9s, syst\u00E8mes et accessoires li\u00E9s aux activit\u00E9s de recherche, d\u00E9veloppement, production, conditionnement, contr\u00F4le qualit\u00E9 et commercialisation des produits et articles repris ci-dessus ; la prestation de tous services scientifiques, techniques, industriels et r\u00E9glementaires, notamment dans le cadre d\u2019activit\u00E9s de type d\u00E9veloppement de proc\u00E9d\u00E9s, transfert de technologies, fabrication pour compte de tiers (CDMO/CMO), recherche contractuelle (CRO), analyses, contr\u00F4le qualit\u00E9, assurance qualit\u00E9, validation, qualification et conformit\u00E9 r\u00E9glementaire ; Le d\u00E9veloppement, l\u2019exploitation et la commercialisation d\u2019\u00E9quipements, plateformes technologiques, proc\u00E9d\u00E9s, m\u00E9thodes, et d\u2019accessoires relatifs aux activit\u00E9s de recherche, d\u00E9veloppement, production et commercialisation des produits et articles repris ci-dessus ; La vente de tous livres ou supports papier ou \u00E9lectronique en rapport avec son objet; et en g\u00E9n\u00E9ral toutes activit\u00E9s int\u00E9ressant l\u0027approvisionnement de l\u0027industrie chimique, pharmaceutique, biotechnologique, des h\u00F4pitaux et cliniques, des officines pharmaceutiques et drogueries, laboratoires et institutions de recherche, ainsi que des mati\u00E8res et produits similaires et connexes. La soci\u00E9t\u00E9 peut de mani\u00E8re g\u00E9n\u00E9rale, entreprendre toutes op\u00E9rations de commerce, d\u0027industrie et de finance, mobili\u00E8res et immobili\u00E8res, dans toutes entreprises dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce/ en tout ou en partie \u00E0 son objet ou qui seraient de nature \u00E0 en faciliter ou \u00E0 d\u00E9velopper la r\u00E9alisation/ La soci\u00E9t\u00E9 peut \u00E9galement exercer toute activit\u00E9 d\u0027ing\u00E9nieur conseil, de bureau d\u0027\u00E9tudes, de conception ou r\u00E9alisation d\u0027appareils ou d\u0027entreprises publique ou priv\u00E9e- y compris l\u0027organisation-rien except\u00E9 ni r\u00E9serv\u00E9. La soci\u00E9t\u00E9 peut s\u0027int\u00E9resser par voie d\u0027apport, de fusion, de souscription, d\u0027association, de cession, ou achat de titres ou droits sociaux, ou de toute autre mani\u00E8re dans toutes soci\u00E9t\u00E9s, entreprises ou associations existantes ou \u00E0 cr\u00E9er en Belgique ou \u00E0 l\u0027\u00E9tranger, dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce/ \u00E0 son objet ou simplement susceptible d\u0027accroitre son activit\u00E9 sociale. La soci\u00E9t\u00E9 pourra acqu\u00E9rir, d\u00E9velopper, exploiter, conc\u00E9der ou c\u00E9der des brevets ou licences ayant trait, directement ou indirectement, aux op\u00E9rations se rapportant \u00E0 l\u0027objet.",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "founding_capital",
      "quote": "Le capital est fix\u00E9 \u00E0 4.238.390 EUR. Il est repr\u00E9sent\u00E9 par 996.268 actions sans d\u00E9signation de valeur nominale",
      "value": {
        "amount": 4238390.0,
        "shares": 996268,
        "currency": "EUR"
      },
      "amount": 4238390.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "amount": "4.238.390",
        "shares": 996268,
        "currency": "EUR"
      }
    },
    {
      "type": "share_issue",
      "quote": "Sambrinvest Spin-Off/Spin-Out SA (BCE 0884.341.575) 63.640 6,39%",
      "value": {
        "count": 63640,
        "percentage": "6,39%"
      },
      "object": "e7",
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "Iris Belgium SRL (BCE 0540.792.024) 176.726 17,74%",
      "value": {
        "count": 176726,
        "percentage": "17,74%"
      },
      "object": "e8",
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "Talence SA (BCE 0841.369.288) 86.890 8,72%",
      "value": {
        "count": 86890,
        "percentage": "8,72%"
      },
      "object": "e9",
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "Vinsovier Soci\u00E9t\u00E9 simple 210.832 21,16%",
      "value": {
        "count": 210832,
        "percentage": "21,16%"
      },
      "object": "e10",
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "CANA Soci\u00E9t\u00E9 simple 58.483 5,87%",
      "value": {
        "count": 58483,
        "percentage": "5,87%"
      },
      "object": "e11",
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "Monsieur Georges Guillaume 3.746 0,38%",
      "value": {
        "count": 3746,
        "percentage": "0,38%"
      },
      "object": "e12",
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "Monsieur Pascal Lizin 3.829 0,38%",
      "value": {
        "count": 3829,
        "percentage": "0,38%"
      },
      "object": "e13",
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "Nomainvest SA (BCE 0460.996.458) 252.041 25,30%",
      "value": {
        "count": 252041,
        "percentage": "25,30%"
      },
      "object": "e14",
      "subject": "e1"
    },
    {
      "type": "share_issue",
      "quote": "Wallonie Entreprendre (BCE 0793.630.244) 140.081 14,06%",
      "value": {
        "count": 140081,
        "percentage": "14,06%"
      },
      "object": "e15",
      "subject": "e1"
    },
    {
      "date": "2025-12-31",
      "type": "net_asset_statement",
      "quote": "Total 5.720.586 EUR ... suite \u00E0 l\u2019apport d\u2019une partie du patrimoine actif et passif de la soci\u00E9t\u00E9 scind\u00E9e \u00E0 la valeur pour laquelle ces \u00E9l\u00E9ments d\u2019actif et de passif figuraient dans la comptabilit\u00E9 de la soci\u00E9t\u00E9 scind\u00E9e au 31 d\u00E9cembre 2025",
      "value": {
        "date": "31 d\u00E9cembre 2025",
        "amount": 5720586,
        "currency": "EUR"
      },
      "amount": 5720586.0,
      "object": null,
      "subject": "e2",
      "currency": "EUR"
    },
    {
      "date": "2025-12-31",
      "type": "accounting_effect",
      "quote": "Les \u00E9l\u00E9ments du patrimoine de la soci\u00E9t\u00E9 scind\u00E9e sont transf\u00E9r\u00E9s sur base de la situation comptable arr\u00EAt\u00E9e \u00E0 la date du 31 d\u00E9cembre 2025.",
      "value": "31 d\u00E9cembre 2025",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "pledge",
      "quote": "La soci\u00E9t\u00E9 comparante d\u00E9clare que le fonds de commerce objet de la scission fait l\u2019objet de trois gages au profit des banques, CBC Banque, ING et BNP Paribas Fortis.",
      "value": "CBC Banque, ING et BNP Paribas Fortis",
      "object": null,
      "subject": "e2"
    },
    {
      "date": "2026-06-25",
      "type": "auditor_report",
      "quote": "Ce rapport dat\u00E9 du 25 juin 2026, conclut dans les termes suivants :",
      "value": "25 juin 2026",
      "object": "e4",
      "subject": "e1"
    },
    {
      "date": "2026-07-15",
      "type": "publication",
      "quote": "publi\u00E9 aux annexes du Moniteur belge sous date et num\u00E9ro 20260526-067087",
      "value": "20260526-067087",
      "object": null,
      "subject": "e2"
    },
    {
      "type": "duration",
      "quote": "La soci\u00E9t\u00E9 est constitu\u00E9e pour une dur\u00E9e illimit\u00E9e.",
      "value": "illimit\u00E9e",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "board_composition",
      "quote": "La soci\u00E9t\u00E9 est administr\u00E9e par un Conseil d\u2019Administration compos\u00E9 de neuf (9) membres au plus",
      "value": "9",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "representation",
      "quote": "La soci\u00E9t\u00E9 est valablement repr\u00E9sent\u00E9e dans tous ses actes, en ce compris la repr\u00E9sentation en justice, par deux administrateurs agissant conjointement",
      "value": "deux administrateurs agissant conjointement",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "auditor",
      "quote": "Le contr\u00F4le de la situation financi\u00E8re, des comptes annuels et de la r\u00E9gularit\u00E9, au regard du Code des soci\u00E9t\u00E9s et des associations et des statuts, des op\u00E9rations \u00E0 constater dans les comptes annuels, est confi\u00E9 \u00E0 un ou plusieurs commissaires nomm\u00E9s par l\u0027assembl\u00E9e g\u00E9n\u00E9rale",
      "value": "un ou plusieurs commissaires",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "real_estate_declaration",
      "quote": "La soci\u00E9t\u00E9 comparante, apr\u00E8s avoir entendu lecture de tout ce qui pr\u00E9c\u00E8de, d\u00E9clare que dans le patrimoine actif et passif transf\u00E9r\u00E9 par la soci\u00E9t\u00E9 anonyme \u00AB BEPHARBEL MANUFACTURING \u00BB \u00E0 la pr\u00E9sente soci\u00E9t\u00E9 ne se trouve compris aucun immeuble.",
      "value": "aucun immeuble",
      "object": null,
      "subject": "e2"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "postfix": [
      "publication date None -\u003E edition 2026-07-15",
      "primary company kbo missing -\u003E register 1040.218.595"
    ],
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 84001,
    "truncated": true
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "1040.218.595",
      "kind": "company",
      "name": "NOVAFORM PHARMA",
      "attrs": {
        "seat": "Rue du Luxembourg 13, 6180 Courcelles",
        "kbo_source": "register",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": "0844.689.955",
      "kind": "company",
      "name": "BEPHARBEL MANUFACTURING",
      "attrs": {
        "seat": "6180 Courcelles, Rue du Luxembourg 13",
        "legal_form": "soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Edouard-Jean NAVEZ",
      "attrs": {
        "role": "notaire associ\u00E9"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "company",
      "name": "Deloitte R\u00E9viseurs d\u0027Entreprises",
      "attrs": {
        "legal_form": "SRL"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Julie Delforge",
      "attrs": {
        "role": "r\u00E9viseur d\u0027entreprises"
      }
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Julia PIEKUNKO",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": "0884.341.575",
      "kind": "company",
      "name": "Sambrinvest Spin-Off/Spin-Out SA",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": "0540.792.024",
      "kind": "company",
      "name": "Iris Belgium SRL",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": "0841.369.288",
      "kind": "company",
      "name": "Talence SA",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "company",
      "name": "Vinsovier Soci\u00E9t\u00E9 simple",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "company",
      "name": "CANA Soci\u00E9t\u00E9 simple",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Georges Guillaume",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "person",
      "name": "Pascal Lizin",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": "0460.996.458",
      "kind": "company",
      "name": "Nomainvest SA",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": "0793.630.244",
      "kind": "company",
      "name": "Wallonie Entreprendre",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "type": "filing",
      "quote": "15 MAI 2026",
      "value": "2026-05-15",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "merger",
      "quote": "Objet de l\u0027acte: Projet de scission partielle par constitution d\u0027une nouvelle soci\u00E9t\u00E9",
      "value": {
        "date": "2026-05-13",
        "type": "scission partielle par constitution d\u0027une nouvelle soci\u00E9t\u00E9"
      },
      "object": "e2",
      "subject": "e1",
      "proposed": true
    },
    {
      "type": "incorporation",
      "quote": "La soci\u00E9t\u00E9 nouvelle issue de la scission sera d\u00E9nomm\u00E9e \u00AB NOVAFORM PHARMA \u00BB. Elle adoptera la forme juridique d\u0027une soci\u00E9t\u00E9 anonyme. Son si\u00E8ge sera \u00E9tabli Rue du Luxembourg, 13 \u00E0 6180 Courcelles.",
      "value": {
        "date": "2026-05-13",
        "seat": "Rue du Luxembourg 13, 6180 Courcelles",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      },
      "object": null,
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "capital_increase",
      "quote": "En r\u00E9mun\u00E9ration du transfert du patrimoine c\u00E9d\u00E9, 996.268 actions nouvelles sans d\u00E9signation de valeur nominale seront \u00E9mises au total par NOVAFORM PHARMA.",
      "value": {
        "shares": 996268,
        "capital": {
          "amount": 4238390,
          "currency": "EUR"
        },
        "share_type": "actions nouvelles sans d\u00E9signation de valeur nominale",
        "share_premium": {
          "amount": 2331154,
          "currency": "EUR"
        }
      },
      "object": null,
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "share_distribution",
      "quote": "Sambrinvest Spin-Off/Spin-Out SA (BCE 0884.341.575) 63.640 6.39%",
      "value": {
        "shares": 63640,
        "percentage": "6.39%"
      },
      "object": "e5",
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "share_distribution",
      "quote": "Iris Belgium SRL (BCE 0540.792.024) 176.726 17,74%",
      "value": {
        "shares": 176726,
        "percentage": "17,74%"
      },
      "object": "e6",
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "share_distribution",
      "quote": "Talence SComm (BCE 0841.369.288) 86.890 8,72%",
      "value": {
        "shares": 86890,
        "percentage": "8,72%"
      },
      "object": "e7",
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "share_distribution",
      "quote": "Vinsovier Soci\u00E9t\u00E9 simple 210.832 21,16%",
      "value": {
        "shares": 210832,
        "percentage": "21,16%"
      },
      "object": "e8",
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "share_distribution",
      "quote": "CANA Soci\u00E9t\u00E9 simple 58.483 5,87%",
      "value": {
        "shares": 58483,
        "percentage": "5,87%"
      },
      "object": "e9",
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "share_distribution",
      "quote": "Monsieur Georges Guillaume 3.746 0,38%",
      "value": {
        "shares": 3746,
        "percentage": "0,38%"
      },
      "object": "e10",
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "share_distribution",
      "quote": "Monsieur Pascal Lizin 3.829 0.38%",
      "value": {
        "shares": 3829,
        "percentage": "0.38%"
      },
      "object": "e11",
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "share_distribution",
      "quote": "Nomainvest SA (BCE 0460.996.458) 252.041 25,30%",
      "value": {
        "shares": 252041,
        "percentage": "25,30%"
      },
      "object": "e12",
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "share_distribution",
      "quote": "Wallonie Entreprendre (BCE 0793.630.244) 140.081 14,06%",
      "value": {
        "shares": 140081,
        "percentage": "14,06%"
      },
      "object": "e13",
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "accounting_effect",
      "quote": "Les op\u00E9rations de la Soci\u00E9t\u00E9 \u00E0 Scinder seront, du point de vue comptable, consid\u00E9r\u00E9es comme accomplies pour compte de NOVAFORM PHARMA \u00E0 compter du 1er janvier 2026 \u00E0 0h00",
      "value": "2026-01-01",
      "object": null,
      "subject": "e2",
      "proposed": true
    },
    {
      "type": "power_of_attorney",
      "quote": "Le conseil d\u0027administration de BEPHARBEL MANUFACTRING SA donne par la pr\u00E9sente procuration \u00E0 Ma\u00EEtre Christophe Krzewinski, avocat... afin de d\u00E9poser le projet de scission et l\u0027ensemble des documents requis au greffe du Tribunal de l\u0027entreprise du Hainaut ainsi que de faire l\u0027ensemble des formalit\u00E9s n\u00E9cessaires \u00E0 la publication au Moniteur belge",
      "value": {
        "date": "2026-05-13",
        "scope": "d\u00E9poser le projet de scission et l\u0027ensemble des documents requis au greffe du Tribunal de l\u0027entreprise du Hainaut ainsi que de faire l\u0027ensemble des formalit\u00E9s n\u00E9cessaires \u00E0 la publication au Moniteur belge"
      },
      "object": "e14",
      "subject": "e1",
      "proposed": true
    },
    {
      "type": "power_of_attorney",
      "quote": "ainsi qu\u0027\u00E0 tout autre avocat du cabinet K/Partners, avec pouvoir de substitution, afin de d\u00E9poser le projet de scission et l\u0027ensemble des documents requis au greffe du Tribunal de l\u0027entreprise du Hainaut ainsi que de faire l\u0027ensemble des formalit\u00E9s n\u00E9cessaires \u00E0 la publication au Moniteur belge",
      "value": {
        "date": "2026-05-13",
        "scope": "d\u00E9poser le projet de scission et l\u0027ensemble des documents requis au greffe du Tribunal de l\u0027entreprise du Hainaut ainsi que de faire l\u0027ensemble des formalit\u00E9s n\u00E9cessaires \u00E0 la publication au Moniteur belge"
      },
      "object": "e15",
      "subject": "e1",
      "proposed": true
    },
    {
      "type": "approval",
      "quote": "La date ultime d\u0027approbation du pr\u00E9sent projet de scission par l\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de la soci\u00E9t\u00E9 \u00E0 Scinder \u00AB BEPHARBEL MANUFACTURING \u003E est fix\u00E9e au 15 juillet 2026.",
      "value": {
        "type": "assembl\u00E9e g\u00E9n\u00E9rale des actionnaires",
        "deadline": "2026-07-15"
      },
      "object": null,
      "subject": "e1",
      "proposed": true
    },
    {
      "type": "incorporation",
      "quote": "La soci\u00E9t\u00E9 anonyme BePharBel Manufacturing, constitu\u00E9e suivant un acte re\u00E7u par le notaire Jean-Philippe Matagne, en date du 20 mars 2012.",
      "value": {
        "date": "2012-03-20",
        "notary": "Jean-Philippe Matagne"
      },
      "object": null,
      "subject": "e1",
      "proposed": true
    },
    {
      "type": "statute_amendment",
      "quote": "Ses statuts ont \u00E9t\u00E9 modifi\u00E9s pour la derni\u00E8re fois en date du 5 mai 2026 suivant un acte re\u00E7u par le Notaire Edouard-Jean Navez, en cours de publication.",
      "value": {
        "date": "2026-05-05",
        "notary": "Edouard-Jean Navez"
      },
      "object": null,
      "subject": "e1",
      "proposed": true
    },
    {
      "type": "publication",
      "quote": "Belgisch Staatsblad - 26/05/2026",
      "value": "2026-05-26",
      "object": null,
      "subject": null
    },
    {
      "type": "purpose",
      "quote": "a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en\nBelgique et \u00E0 l\u0027\u00E9tranger, la recherche, la fabrication, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation\net l\u0027exportation, et la transformation:\n-de tous produits chimiques, pharmaceutiques, di\u00E9t\u00E9tiques, phytopharmaceutiques, hom\u00E9opathiques,\nv\u00E9t\u00E9rinaires et d\u0027herboristerie;\n-de tous articles de droguerie en g\u00E9n\u00E9ral, de parfumerie, de cosm\u00E9tiques, d\u0027hygi\u00E8ne et d\u0027entretien;\n-d\u0027accessoires m\u00E9dicaux et chirurgicaux, d\u0027acoustique, d\u0027optique, d\u0027orthop\u00E9die et de bandages; de tous\nautres produits se rapportant d\u0027une fa\u00E7on quelconque aux articles repris ci-dessus et pouvant y \u00EAtre adjoint",
      "value": "tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et \u00E0 l\u0027\u00E9tranger, la recherche, la fabrication, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation et l\u0027exportation, et la transformation: -de tous produits chimiques, pharmaceutiques, di\u00E9t\u00E9tiques, phytopharmaceutiques, hom\u00E9opathiques, v\u00E9t\u00E9rinaires et d\u0027herboristerie; -de tous articles de droguerie en g\u00E9n\u00E9ral, de parfumerie, de cosm\u00E9tiques, d\u0027hygi\u00E8ne et d\u0027entretien; -d\u0027accessoires m\u00E9dicaux et chirurgicaux, d\u0027acoustique, d\u0027optique, d\u0027orthop\u00E9die et de bandages; de tous autres produits se rap",
      "object": null,
      "subject": null,
      "proposed": true
    },
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Projet de scission partielle par constitution d\u0027une nouvelle soci\u00E9t\u00E9",
      "value": "Projet de scission partielle par constitution d\u0027une nouvelle soci\u00E9t\u00E9",
      "object": null,
      "subject": null
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 27741,
    "truncated": false,
    "needs_verify": true
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0844.689.955",
      "kind": "company",
      "name": "BEPHARBEL MANUFACTURING",
      "attrs": {
        "seat": "Rue du Luxembourg 13, 6180 Courcelles",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "company",
      "name": "NOVAFORM PHARMA",
      "attrs": {
        "seat": "Rue du Luxembourg 13, 6180 Courcelles",
        "status": "Soci\u00E9t\u00E9 \u00E0 Constituer",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Jean-Philippe Matagne",
      "attrs": {
        "role": "notaire"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Edouard-Jean Navez",
      "attrs": {
        "role": "Notaire"
      }
    },
    {
      "id": "e5",
      "kbo": "0884.341.575",
      "kind": "company",
      "name": "Sambrinvest Spin-Off/Spin-Out SA",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": "0540.792.024",
      "kind": "company",
      "name": "Iris Belgium SRL",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": "0841.369.288",
      "kind": "company",
      "name": "Talence SComm",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "company",
      "name": "Vinsovier Soci\u00E9t\u00E9 simple",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "company",
      "name": "CANA Soci\u00E9t\u00E9 simple",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Georges Guillaume",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Pascal Lizin",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": "0460.996.458",
      "kind": "company",
      "name": "Nomainvest SA",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": "0793.630.244",
      "kind": "company",
      "name": "Wallonie Entreprendre",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Christophe Krzewinski",
      "attrs": {
        "role": "avocat"
      }
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "org",
      "name": "K/Partners",
      "attrs": {
        "type": "cabinet d\u0027avocats"
      }
    },
    {
      "id": "e16",
      "kbo": null,
      "kind": "person",
      "name": "Vincent STEPHENNE",
      "attrs": {
        "role": "Administrateur d\u00E9l\u00E9gu\u00E9"
      }
    },
    {
      "id": "e17",
      "kbo": null,
      "kind": "person",
      "name": "Bernard Jolly",
      "attrs": {
        "role": "Pr\u00E9sident du Conseil d\u0027Administration"
      }
    }
  ]
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte: Fusion par absorption de la SA BePharBel",
      "value": "Fusion par absorption de la SA BePharBel",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-02-27",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 27/02/2025 - Annexes du Moniteur belge",
      "value": "27/02/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2025-02-19",
      "type": "filing",
      "quote": "19 FEV. 2025",
      "value": "19/02/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "merger",
      "quote": "Extrait du projet de fusion \u00E9tabli conjointement par le Conseil d\u0027administration de BePharBel SA et de BePharBel Manufacturing SA",
      "value": {
        "proposed": true
      },
      "object": "e2",
      "status": "proposed",
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "Son objet social est le suivant: ...",
      "value": "La soci\u00E9t\u00E9 a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et \u00E0 l\u0027\u00E9tranger, la recherche, la fabrication, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation et l\u0027exportation, et la transformation: -de tous produits chimiques, pharmaceutiques, di\u00E9t\u00E9tiques, phytopharmaceutiques, hom\u00E9opathiques, v\u00E9t\u00E9rinaires et d\u0027herboristerie; -de tous articles de droguerie en g\u00E9n\u00E9ral, de parfumerie, de cosm\u00E9tiques, d\u0027hygi\u00E8ne et d\u0027entretien; -d\u0027accessoires m\u00E9dicaux et chirurgicaux, d\u0027acoustique, d\u0027optique, d\u0027orthop\u00E9die et de bandages; de tous autres produits se rapportant d\u0027une fa\u00E7on quelconque aux articles repris ci-dessus et pouvant y \u00EAtre adjoints utilement; -Le d\u00E9veloppement, l\u0027exploitation et la commercialisation d\u0027\u00E9quipements et d\u0027accessoires relatifs aux activit\u00E9s de recherche, d\u00E9veloppement, production et commercialisation des produits et articles repris ci-dessus -La vente de tous livres ou supports papier ou \u00E9lectronique en rapport avec son objet; et en g\u00E9n\u00E9ral toutes activit\u00E9s int\u00E9ressant l\u0027approvisionnement de l\u0027industrie chimique, des h\u00F4pitaux et cliniques, des officines pharmaceutiques et drogueries ainsi que des mati\u00E8res et produits similaires et connexes. La soci\u00E9t\u00E9 peut de mani\u00E8re g\u00E9n\u00E9rale, entreprendre toutes op\u00E9rations de commerce, d\u0027industrie et de finance, mobili\u00E8res et immobili\u00E8res, dans toutes entreprises dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce/ en tout ou en partie \u00E0 son objet ou qui seraient de nature \u00E0 en faciliter ou \u00E0 d\u00E9velopper la r\u00E9alisation/ La soci\u00E9t\u00E9 peut \u00E9galement exercer toute activit\u00E9 d\u0027ing\u00E9nieur conseil, de bureau d\u0027\u00E9tudes, de conception ou r\u00E9alisation d\u0027appareils ou d\u0027entreprises publique ou priv\u00E9e- y compris l\u0027organisation- rien except\u00E9 ni r\u00E9serv\u00E9. La soci\u00E9t\u00E9 peut s\u0027int\u00E9resser par voie d\u0027apport, de fusion, de souscription, d\u0027association, de cession, ou achat de titres ou droits sociaux, ou de toute autre mani\u00E8re dans toutes soci\u00E9t\u00E9s, entreprises ou associations existantes ou \u00E0 cr\u00E9er en Belgique ou \u00E0 l\u0027\u00E9tranger, dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce/ \u00E0 son objet ou simplement susceptible d\u0027accroitre son activit\u00E9 sociale. La soci\u00E9t\u00E9 pourra acqu\u00E9rir, exploiter et c\u00E9der des brevets ou licences ayant trait, directement ou indirectement, aux op\u00E9rations se rapportant \u00E0 l\u0027objet. Cette \u00E9num\u00E9ration est simplement \u00E9nonciative et nullement limitative.",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "purpose",
      "quote": "Son objet social est le suivant : ...",
      "value": "La soci\u00E9t\u00E9 a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et \u00E0 l\u0027\u00E9tranger, la recherche, la fabrication, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation et l\u0027exportation, et la transformation : -de tous produits chimiques, pharmaceutiques, di\u00E9t\u00E9tiques, phytopharmaceutiques, hom\u00E9opathiques, v\u00E9t\u00E9rinaires et d\u0027herboristerie: -de tous articles de droguerie en g\u00E9n\u00E9ral, de parfumerie, de cosm\u00E9tiques, d\u0027hygi\u00E8ne et d\u0027entretien; -d\u0027accessoires m\u00E9dicaux et chirurgicaux, d\u0027acoustique, d\u0027optique, d\u0027orthop\u00E9die et de bandages; de tous autres produits se rapportant d\u0027une fa\u00E7on quelconque aux articles repris ci-dessus et pouvant y \u00EAtre adjoints utilement: -Le d\u00E9veloppement, l\u0027exploitation et la commercialisation d\u0027\u00E9quipements et d\u0027accessoires relatifs aux activit\u00E9s de recherche, d\u00E9veloppement, production et commercialisation des produits et articles repris ci-dessus - La vente de tous livres ou supports papier ou \u00E9lectronique en rapport avec son objet; et en g\u00E9n\u00E9ral toutes activit\u00E9s int\u00E9ressant l\u0027approvisionnement de l\u0027industrie chimique, des h\u00F4pitaux et cliniques, des officines pharmaceutiques et drogueries ainsi que des mati\u00E8res et produits similaires et connexes. La soci\u00E9t\u00E9 peut de mani\u00E8re g\u00E9n\u00E9rale, entreprendre toutes op\u00E9rations de commerce, d\u0027industrie et de finance, mobili\u00E8res et immobili\u00E8res, dans toutes entreprises dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce, en tout ou en partie \u00E0 son objet ou qui seraient de nature \u00E0 en faciliter ou \u00E0 d\u00E9velopper la r\u00E9alisation. La soci\u00E9t\u00E9 peut \u00E9galement exercer toute activit\u00E9 d\u0027ing\u00E9nieur conseil, de bureau d\u0027\u00E9tudes, de conception ou r\u00E9alisation d\u0027appareils ou d\u0027entreprises publique ou priv\u00E9e - y compris l\u0027organisation - rien except\u00E9 ni r\u00E9serv\u00E9. La soci\u00E9t\u00E9 peut s\u0027int\u00E9resser par voie d\u0027apport, de fusion, de souscription, d\u0027association, de cession, ou achat de titres ou droits sociaux, ou de toute autre mani\u00E8re dans toutes soci\u00E9t\u00E9s, entreprises ou associations existantes ou \u00E0 cr\u00E9er en Belgique ou \u00E0 l\u0027\u00E9tranger, dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce, \u00E0 son objet ou simplement susceptible d\u0027accroitre son activit\u00E9 sociale. La soci\u00E9t\u00E9 pourra acqu\u00E9rir, exploiter et c\u00E9der des brevets ou licences ayant trait, directement ou indirectement, aux op\u00E9rations se rapportant \u00E0 l\u0027objet. Cette \u00E9num\u00E9ration est simplement \u00E9nonciative et nullement limitative",
      "object": null,
      "subject": "e2"
    },
    {
      "type": "share_issue",
      "quote": "la Soci\u00E9t\u00E9 Absorbante \u00E9mettra 87.928 actions nouvelles",
      "value": {
        "count": 87928,
        "reason": "fusion"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "share_cancellation",
      "quote": "proposer \u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale des actionnaires de d\u00E9cider imm\u00E9diatement apr\u00E8s la Fusion de d\u00E9truire ces 87.928 actions propres",
      "value": {
        "count": 87928,
        "reason": "actions propres acquises suite \u00E0 la fusion"
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_decrease",
      "quote": "r\u00E9duire les fonds propres de la Soci\u00E9t\u00E9 Absorbante en cons\u00E9quence. Cette r\u00E9duction des fonds propres correspondra au montant \u00E9quivalent \u00E0 la valeur de la participation dans la Soci\u00E9t\u00E9 Absorbante reprises dans le bilan de la Soci\u00E9t\u00E9 Absorb\u00E9e au 31 d\u00E9cembre 2024 sous la rubrique \u003C immobilisations financi\u00E8res \u00BB\u003E, \u00E0 savoir: 1.206.755 \u20AC.",
      "value": {
        "amount": 1206755,
        "reason": "destruction des actions propres",
        "currency": "EUR"
      },
      "amount": 1206755.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR"
    },
    {
      "date": "2025-01-01",
      "type": "accounting_effect",
      "quote": "La Fusion prendra effet le 1er janvier 2025 \u00E0 0.00 heure. Les op\u00E9rations de la Soci\u00E9t\u00E9 Absorb\u00E9e seront consid\u00E9r\u00E9es du point de vue comptable comme accomplies pour le compte de la Soci\u00E9t\u00E9 Absorbante \u00E0 partir de cette date.",
      "value": "01/01/2025",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "auditor_appointment",
      "quote": "Le rapport relatif \u00E0 l\u0027augmentation du capital par apport en nature sera \u00E9tabli, conform\u00E9ment aux articles 7:179 et 7:197 du CSA, par le commissaire des deux Soci\u00E9t\u00E9s: Deloitte R\u00E9viseurs d\u0027Entreprises SRL, repr\u00E9sent\u00E9e par Julie Delforge.",
      "value": {
        "role": "commissaire pour rapport augmentation capital par apport en nature"
      },
      "object": "e1",
      "subject": "e13"
    },
    {
      "type": "filing_representative",
      "quote": "Pour copie conforme Thibault Neuzy Mandataire",
      "value": null,
      "object": "e1",
      "subject": "e15"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 15127,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0844.689.955",
      "kind": "company",
      "name": "BePharBel Manufacturing SA",
      "attrs": {
        "seat": "Rue du Luxembourg, 13 \u00E0 6180 Courcelles",
        "legal_form": "soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": "0843.905.938",
      "kind": "company",
      "name": "BePharBel SA",
      "attrs": {
        "seat": "Rue du Luxembourg, 13 \u00E0 6180 Courcelles",
        "legal_form": "soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e3",
      "kbo": "0884.341.575",
      "kind": "company",
      "name": "Sambrinvest Spin-Off/Spin-Out SA",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": "0540.792.024",
      "kind": "company",
      "name": "Iris Belgium SRL",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": "0841.369.288",
      "kind": "company",
      "name": "Talence SComm",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "company",
      "name": "Vinsovier Soci\u00E9t\u00E9 simple",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "company",
      "name": "CANA Soci\u00E9t\u00E9 simple",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Georges Guillaume",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Pascal Lizin",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": "0460.996.458",
      "kind": "company",
      "name": "Nomainvest SA",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Vincent St\u00E9phenne",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": "0793.630.244",
      "kind": "company",
      "name": "Wallonie Entreprendre",
      "attrs": {}
    },
    {
      "id": "e13",
      "kbo": null,
      "kind": "company",
      "name": "Deloitte R\u00E9viseurs d\u0027Entreprises SRL",
      "attrs": {}
    },
    {
      "id": "e14",
      "kbo": null,
      "kind": "person",
      "name": "Julie Delforge",
      "attrs": {}
    },
    {
      "id": "e15",
      "kbo": null,
      "kind": "person",
      "name": "Thibault Neuzy",
      "attrs": {}
    }
  ]
}

{
  "events": [
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "ODELENS CONSULT",
        "address": null,
        "birth_date": null,
        "profession": null,
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": {
        "kbo": null,
        "name": "ODELENS CONSULT SRL",
        "address": null,
        "country": null,
        "legal_form": "SRL"
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le conseil d\u0027administration d\u00E9cide de d\u00E9signer un d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion jouranli\u00E8re, et attribue cette fonction \u00E0 ODELENS CONSULT SRL, repr\u00E9sent\u00E9e par Olivier Delens. ODELENS CONSULT \u00E9tant \u00E9galement admininistrateur de la Soci\u00E9t\u00E9, elle portera le titre d\u0027administrateur d\u00E9l\u00E9gu\u00E9. Ce mandat restera en v",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "until_agm_year",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    },
    {
      "kind": "delegation_dagelijks_bestuur_in",
      "role": "dagelijks_bestuur",
      "person": {
        "rrn": null,
        "name": "Arnaud Van Grambezen",
        "address": null,
        "birth_date": null,
        "profession": "avocat",
        "birth_place": null
      },
      "reason": null,
      "subkind": "additional",
      "via_org": {
        "kbo": null,
        "name": "Ethikos",
        "address": "1000 Bruxelles, Avenue Louise 66/12",
        "country": "BE",
        "legal_form": null
      },
      "statutory": null,
      "compensated": null,
      "effective_date": null,
      "evidence_quote": "Le conseil d\u0027administration donne mandat \u00E0 Me Arnaud Van Grambezen ainsi qu\u0027\u00E0 tout autre avocat du cabinet Ethikos, dont les bureaux sont \u00E9tablis \u00E0 1000 Bruxelles, Avenue Louise 66/12, chacun pouvant agir individuellement et avec pouvoir de substitution aux fins de veiller aux formalit\u00E9s de publicat",
      "decharge_status": null,
      "mandate_duration": {
        "kind": "indefinite",
        "value": null
      },
      "rep_rotation_new_rep": null,
      "rep_rotation_old_rep": null,
      "effective_date_qualifier": null
    }
  ],
  "notary": {
    "name": null,
    "firm_city": null,
    "firm_name": null,
    "office_city": "Uccle",
    "is_associated": false
  },
  "act_meta": {
    "language": "mixed",
    "pub_date": null,
    "filing_date": "2023-05-17",
    "act_kind_objet": "Objet de l\u0027acte:"
  },
  "decisions": [
    {
      "body": "conseil_d_administration",
      "date": "2023-04-26",
      "unanimous": null
    }
  ],
  "is_correction": false,
  "subject_company": {
    "kbo": "0841.369.288",
    "name_full": "Talence",
    "legal_form": "Soci\u00E9t\u00E9 anonyme"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Arnaud Van Grambezen",
    "org_rep_person_name": null,
    "person_role_at_subject": "Mandataire sp\u00E9cial"
  },
  "co_filed_documents": [],
  "corrected_publication_numac": null
}

{
  "facts": [
    {
      "type": "act_object",
      "quote": "Objet de l\u0027acte : Op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption - d\u00E9p\u00F4t du projet de fusion",
      "value": "Op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption - d\u00E9p\u00F4t du projet de fusion",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2015-05-07",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 07/05/2015 - Annexes du Moniteur belge",
      "value": "07/05/2015",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2015-04-24",
      "type": "filing",
      "quote": "apr\u00E8s d\u00E9p\u00F4t de l\u0027acte aufon de Charlerot eto 24 AVR. 2015",
      "value": "24/04/2015",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2014-12-31",
      "type": "act_date",
      "quote": "Fait \u00E0 Courcelles, le 31 d\u00E9cembre 2014",
      "value": "31/12/2014",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "merger",
      "quote": "projet d\u0027une op\u00E9ration assimil\u00E9e \u00E0 une fusion par absorption de la BVBA ECONOPHAR ... par la S.A. BEPHARBEL MANUFACTURING",
      "value": {
        "proposed": true
      },
      "object": "e2",
      "status": "proposed",
      "subject": "e1"
    },
    {
      "date": "2015-01-01",
      "type": "accounting_effect",
      "quote": "La fusion prend effet au 1er janvier 2015.",
      "value": "01/01/2015",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital",
      "quote": "Son capital est fix\u00E9 \u00E0 deux millions cinq cent soixante-quatre mille sept cent quatre-vingts euros (2.564.780,00\u20AC) repr\u00E9sent\u00E9 par deux cent cinquante-six mille quatre cent septante-huit (256.478) actions",
      "value": {
        "amount": 2564780.0,
        "shares": 256478,
        "currency": "EUR"
      },
      "amount": 2564780.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "amount": "2.564.780,00",
        "shares": 256478,
        "currency": "EUR"
      }
    },
    {
      "type": "purpose",
      "quote": "Son objet social est ainsi libell\u00E9 : \u003C La soci\u00E9t\u00E9 a pour objet...",
      "value": "La soci\u00E9t\u00E9 a pour objet, tant pour compte propre que compte de tiers ou en participation avec des tiers, en Belgique et \u00E0 l\u0027\u00E9tranger, la recherche, la fabrication, l\u0027industrie, l\u0027achat, la vente, le conditionnement, l\u0027importation et l\u0027exportation, et la transformation: De tous produits chimiques, pharmaceutiques, di\u00E9t\u00E9tiques, phytopharmaceutiques, hom\u00E9opathiques, v\u00E9t\u00E9rinaires et d\u0027herboristerie; De tous les articles de droguerie en g\u00E9n\u00E9ral, de parfumerie, de cosm\u00E9tiques, d\u0027hygi\u00E8ne et d\u0027entretien; D\u0027accessoires m\u00E9dicaux et chirurgicaux, d\u0027acoustique, d\u0027optique, d\u0027orthop\u00E9die et de bandages; de tous autres produits se rapportant d\u0027une fa\u00E7on quelconque aux articles repris ci-dessus et pouvant y \u00EAtre adjoints utilement; Le d\u00E9veloppement, l\u0027exploitation et la commercialisation d\u0027\u00E9quipements et d\u0027accessoires relatifs aux activit\u00E9s de recherche, d\u00E9veloppement, production et commercialisation des produits et articles repris ci-dessus La vente de tous livres ou supports papier ou \u00E9lectronique en rapport avec son objet social; et en g\u00E9n\u00E9ral toutes activit\u00E9s int\u00E9ressant l\u0027approvisionnement de l\u0027industrie chimique, des h\u00F4pitaux et cliniques, des officines pharmaceutiques et drogueries ainsi que des mati\u00E8res et produits similaires et connexes. La soci\u00E9t\u00E9 peut de mani\u00E8re g\u00E9n\u00E9rale, entreprendre toutes op\u00E9rations de commerce, d\u0027industrie et de finance, mobili\u00E8res et immobili\u00E8res, dans toutes entreprises dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce/ en tout ou en en partie \u00E0 son objet social ou qui seraient de nature \u00E0 en faciliter ou \u00E0 d\u00E9velopper la r\u00E9alisation. La soci\u00E9t\u00E9 peut \u00E9galement exercer toute activit\u00E9 d\u0027ing\u00E9nieur conseil, de bureau d\u0027\u00E9tudes, de conception ou r\u00E9alisation d\u0027appareils ou d\u0027entreprises publiques ou priv\u00E9es - y compris l\u0027organisation-rien except\u00E9 ni r\u00E9serv\u00E9. La soci\u00E9t\u00E9 peut s\u0027int\u00E9resser par voie d\u0027apport, de fusion, de souscription, d\u0027association, de cession, ou achat de titres ou drolts sociaux, ou de toute autre mani\u00E8re dans toutes soci\u00E9t\u00E9s, entreprises ou associations existantes ou \u00E0 cr\u00E9er en Belgique ou \u00E0 l\u0027\u00E9tranger, dont l\u0027objet se rattache directement ou indirectement \u00E0 son industrie ou son commerce, \u00E0 son objet social ou simplement susceptible d\u0027accro\u00EEtre son activit\u00E9 sociale. La soci\u00E9t\u00E9 pourra acqu\u00E9rir, exploiter et c\u00E9der des brevets ou licences ayant trait, directement ou indirectement, aux op\u00E9rations se rapportant \u00E0 l\u0027objet social. Cette \u00E9num\u00E9ration est simplement \u00E9nonciative et nullement limitative.",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital",
      "quote": "Son capital est fix\u00E9 \u00E0 dix-huit mille cinq cent nonante-deux euros (18.592\u20AC) repr\u00E9sent\u00E9 par sept cent cinquante parts sociales.",
      "value": {
        "amount": 18592.0,
        "shares": 750,
        "currency": "EUR"
      },
      "amount": 18592.0,
      "object": null,
      "subject": "e2",
      "currency": "EUR",
      "_value_raw": {
        "amount": "18.592",
        "shares": 750,
        "currency": "EUR"
      }
    },
    {
      "type": "purpose",
      "quote": "Son objet soc\u00EDal est ainsi libell\u00E9: \u003C\u003C Groothandel...",
      "value": "Groothandel, invoer, uitvoer van farmaceutische specialiteiten, paramedische producten, labo en medisch materiaal, reagentia voor labo, cosmetische produoten, consulting farmaceutische aangelegenheden en of andere in verband met vermelde activiteiten, machines en fabricage van farmaceutische, cosmetische, medische, paramedische en allerlei producten in verband met de hierboven vermelde activiteiten. De vennootschap zal in het algemeen alle commerci\u00EBle, industri\u00EBle, financi\u00EBle, roerende en onroerende handelingen mogen verrichten in rechtstreekse of onrechtstreeks verband met haar maatschappelijk doel of welke van die aard zouden z\u00EDjn dat zij het bereiken ervan geheel of ten dele vergemakkelijken.",
      "object": null,
      "subject": "e2"
    },
    {
      "type": "shareholding",
      "quote": "La soci\u00E9t\u00E9 absorbante est en effet propri\u00E9taire directe de 100% des parts sociales de la soci\u00E9t\u00E9 absorb\u00E9e.",
      "value": {
        "percentage": 100
      },
      "object": "e2",
      "subject": "e1"
    }
  ],
  "act_meta": {
    "outcome": "corrected",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 10428,
    "truncated": false,
    "completeness_doubt": [
      "Shareholding of BEPHARBEL MANUFACTURING (e1) with 13 shareholders and percentages",
      "Board of directors of BEPHARBEL MANUFACTURING (e1) including delegated administrator and representative",
      "Manager of ECONOPHAR (e2): Vincent STEPHENNE",
      "Notaries: Jean-Philippe MATAGNE (for e1) and Serge COLLON-WINDELINCKX (for e2)"
    ]
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0844.689.955",
      "kind": "company",
      "name": "BEPHARBEL MANUFACTURING",
      "attrs": {
        "seat": "rue du Luxembourg, 13 \u00E0 6180 Courcelles",
        "legal_form": "Soci\u00E9t\u00E9 Anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": "0432.322.862",
      "kind": "company",
      "name": "ECONOPHAR",
      "attrs": {
        "seat": "Arthur De Coninckstraat, 13 \u00E0 3070 Kortenberg",
        "legal_form": "BVBA"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Vincent STEPHENNE",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": "0841.369.288",
      "kind": "company",
      "name": "TALENCE",
      "attrs": {
        "legal_form": "Sca"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Jacques DELENS",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Antoine de Rochechouart de Montemart",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Wolf LANDAU",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Anne PRIGNON",
      "attrs": {}
    },
    {
      "id": "e9",
      "kbo": null,
      "kind": "person",
      "name": "Jacques REYMANN",
      "attrs": {}
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Jean STEPHENNE",
      "attrs": {}
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Christian VANDECASSERIE",
      "attrs": {}
    },
    {
      "id": "e12",
      "kbo": null,
      "kind": "person",
      "name": "Cyril WOLKONSKY",
      "attrs": {}
    }
  ]
}

{
  "facts": [
    {
      "date": "2014-07-17",
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 17/07/2014",
      "value": "17/07/2014",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2014-07-09",
      "type": "filing",
      "quote": "Tribunal de commerce de Charleroi ... 09 JUL, 2014",
      "value": "09/07/2014",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2014-06-26",
      "type": "notarial_deed",
      "quote": "Extrait du proc\u00E8s-verbal dress\u00E9 par Jean-Philippe MATAGNE, notaire \u00E0 Charleroi, le 26 juin 2014",
      "value": "26/06/2014",
      "object": "e4",
      "subject": "e1"
    },
    {
      "date": "2014-06-26",
      "type": "general_meeting",
      "quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale a d\u00E9cid\u00E9 ... le 26 juin 2014",
      "value": "26/06/2014",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "capital_increase",
      "quote": "PREMIERE AUGMENTATION DE CAPITAL: ... porter de 1 072 800,00 \u20AC \u00E0 1 187 000,00 \u20AC ... cr\u00E9ation de 11 420 actions nouvelles ... prime d\u0027\u00E9mission fix\u00E9e \u00E0 26,00 \u20AC par action ... prix de souscription ... 36,00 \u20AC ... diff\u00E9rence ... 296 920,00 \u20AC",
      "value": {
        "after": "1 187 000,00 \u20AC",
        "delta": "114 200,00 \u20AC",
        "amount": 1187000.0,
        "before": "1 072 800,00 \u20AC",
        "method": "apports en nature de cr\u00E9ances certaines et liquides",
        "shares": "11 420",
        "premium": "296 920,00 \u20AC",
        "currency": "EUR",
        "nominal_value": "10,00 \u20AC",
        "subscription_price": "36,00 \u20AC"
      },
      "amount": 114200.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "1 187 000,00 \u20AC",
        "delta": "114 200,00 \u20AC",
        "before": "1 072 800,00 \u20AC",
        "method": "apports en nature de cr\u00E9ances certaines et liquides",
        "shares": "11 420",
        "premium": "296 920,00 \u20AC",
        "nominal_value": "10,00 \u20AC",
        "subscription_price": "36,00 \u20AC"
      }
    },
    {
      "type": "capital_increase",
      "quote": "DEUXIEME AUGMENTATION DE CAPITAL: ... porter de 1 187 000,00 \u20AC \u00E0 2 564 780,00 \u20AC ... cr\u00E9ation de 137 778 actions nouvelles ... prime d\u0027\u00E9mission fix\u00E9e \u00E0 35,00 \u20AC ... prix de souscription ... 45,00 \u20AC ... diff\u00E9rence ... 4 822 230,00 \u20AC",
      "value": {
        "after": "2 564 780,00 \u20AC",
        "delta": "1 377 780,00 \u20AC",
        "amount": 2564780.0,
        "before": "1 187 000,00 \u20AC",
        "method": "apports en esp\u00E8ces",
        "shares": "137 778",
        "premium": "4 822 230,00 \u20AC",
        "currency": "EUR",
        "nominal_value": "10,00 \u20AC",
        "subscription_price": "45,00 \u20AC"
      },
      "amount": 1377780.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "after": "2 564 780,00 \u20AC",
        "delta": "1 377 780,00 \u20AC",
        "before": "1 187 000,00 \u20AC",
        "method": "apports en esp\u00E8ces",
        "shares": "137 778",
        "premium": "4 822 230,00 \u20AC",
        "nominal_value": "10,00 \u20AC",
        "subscription_price": "45,00 \u20AC"
      }
    },
    {
      "type": "capital",
      "quote": "Article 5: ... Le capital social est fix\u00E9 \u00E0 deux millions cinq cent soixante-quatre mille sept cent quatre-vingt euros (2 564 780,00 \u20AC). Il est repr\u00E9sent\u00E9 par 256 478 actions",
      "value": {
        "amount": 2564780.0,
        "shares": "256 478",
        "currency": "EUR"
      },
      "amount": 2564780.0,
      "object": null,
      "subject": "e1",
      "currency": "EUR",
      "_value_raw": {
        "amount": "2 564 780,00 \u20AC",
        "shares": "256 478"
      }
    },
    {
      "type": "bank_account",
      "quote": "versement en esp\u00E8ces effectu\u00E9 au compte aupr\u00E8s de ING ouvert au nom de la soci\u00E9t\u00E9 anonyme BePharbel Manufacturing",
      "value": "ING",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "statute_amendment",
      "quote": "Article 13: Pour remplacer au premier alin\u00E9a les mots \u003C huit (8) membres au plus \u00BB par les mots \u003C\u003C neuf (9) membres au plus \u00BB.",
      "value": "Article 13: remplacement de \u0027huit (8) membres au plus\u0027 par \u0027neuf (9) membres au plus\u0027",
      "object": null,
      "subject": "e1"
    },
    {
      "date": "2014-06-26",
      "type": "officer_resignation",
      "quote": "L\u0027assembl\u00E9e a pris acte de la d\u00E9mission de son poste d\u0027administrateur \u00E0 compter de ce jour de la soci\u00E9t\u00E9 anonyme SAMBRINVEST SPIN OFF SPIN OUT",
      "value": {
        "date": "2014-06-26",
        "role": "administrateur"
      },
      "object": null,
      "subject": "e5",
      "_value_raw": {
        "date": "26/06/2014",
        "role": "administrateur"
      }
    },
    {
      "date": "2014-06-26",
      "type": "officer_appointment",
      "quote": "L\u0027assembl\u00E9e a d\u00E9cid\u00E9 de nommer trois nouveaux administrateurs: \u2022Monsieur Cynil WOLKONSKY",
      "value": {
        "role": "administrateur",
        "start_date": "2014-06-26"
      },
      "object": null,
      "subject": "e7",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "26/06/2014"
      }
    },
    {
      "date": "2014-06-26",
      "type": "officer_appointment",
      "quote": "L\u0027assembl\u00E9e a d\u00E9cid\u00E9 de nommer trois nouveaux administrateurs: \u2022Monsieur Antoine de ROCHECHOUART de MORTEMART",
      "value": {
        "role": "administrateur",
        "start_date": "2014-06-26"
      },
      "object": null,
      "subject": "e8",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "26/06/2014"
      }
    },
    {
      "date": "2014-06-26",
      "type": "officer_appointment",
      "quote": "L\u0027assembl\u00E9e a d\u00E9cid\u00E9 de nommer trois nouveaux administrateurs: \u2022La soci\u00E9t\u00E9 en commandite par actions TALENCE",
      "value": {
        "role": "administrateur",
        "start_date": "2014-06-26"
      },
      "object": null,
      "subject": "e9",
      "_value_raw": {
        "role": "administrateur",
        "start_date": "26/06/2014"
      }
    },
    {
      "type": "permanent_representative",
      "quote": "SAMBRINVEST SPIN OFF SPIN OUT, dont le repr\u00E9sentant permanent est Monsieur Fabrice CAROSELLA",
      "value": null,
      "object": "e5",
      "subject": "e6"
    },
    {
      "type": "permanent_representative",
      "quote": "TALENCE ... repr\u00E9sent\u00E9e par son repr\u00E9sentant permanent Monsieur Jean-Jacques DELENS",
      "value": null,
      "object": "e9",
      "subject": "e10"
    }
  ],
  "act_meta": {
    "outcome": "clean",
    "model_id": 50,
    "verified": true,
    "extractor": "verified-v1",
    "ocr_chars": 10910,
    "truncated": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0844.689.955",
      "kind": "company",
      "name": "BePharBel Manufacturing",
      "attrs": {
        "seat": "6180-Courcelles - rue du Luxembourg, 13",
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e2",
      "kbo": "0429.053.863",
      "kind": "company",
      "name": "DELOITTE R\u00E9viseurs d\u0027Entreprises",
      "attrs": {
        "seat": "1831-Diegem, Berkenlaan, 8b",
        "legal_form": "SCRL"
      }
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Julie DELFORGE",
      "attrs": {}
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Jean-Philippe MATAGNE",
      "attrs": {
        "address": "Charleroi"
      }
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "company",
      "name": "SAMBRINVEST SPIN OFF SPIN OUT",
      "attrs": {
        "legal_form": "Soci\u00E9t\u00E9 anonyme"
      }
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Fabrice CAROSELLA",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Cynil WOLKONSKY",
      "attrs": {
        "address": "1000-Bruxelles, avenue de l\u0027Aurore, 22"
      }
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "person",
      "name": "Antoine de ROCHECHOUART de MORTEMART",
      "attrs": {
        "address": "Londres SW3 6DT (Grande Bretagne), Mallord street, 13"
      }
    },
    {
      "id": "e9",
      "kbo": "0841.369.288",
      "kind": "company",
      "name": "TALENCE",
      "attrs": {
        "seat": "Uccle (1180-Bruxelles), avenue du Vivier d\u0027Oie, 57",
        "legal_form": "Soci\u00E9t\u00E9 en commandite par actions"
      }
    },
    {
      "id": "e10",
      "kbo": null,
      "kind": "person",
      "name": "Jean-Jacques DELENS",
      "attrs": {
        "address": "Uccle (1180-Bruxelles), avenue du Vivier d\u0027Oie, 57"
      }
    },
    {
      "id": "e11",
      "kbo": null,
      "kind": "person",
      "name": "Geoffroy FALMAGNE",
      "attrs": {}
    }
  ]
}